206 related articles for article (PubMed ID: 9819791)
1. Role of hepatocyte growth factor and its receptor c-met in multiple myeloma.
Seidel C; Børset M; Hjorth-Hansen H; Sundan A; Waage A
Med Oncol; 1998 Sep; 15(3):145-53. PubMed ID: 9819791
[TBL] [Abstract][Full Text] [Related]
2. Cell surface proteoglycan syndecan-1 mediates hepatocyte growth factor binding and promotes Met signaling in multiple myeloma.
Derksen PW; Keehnen RM; Evers LM; van Oers MH; Spaargaren M; Pals ST
Blood; 2002 Feb; 99(4):1405-10. PubMed ID: 11830493
[TBL] [Abstract][Full Text] [Related]
3. Myeloma-derived extracellular vesicles mediate HGF/c-Met signaling in osteoblast-like cells.
Strømme O; Psonka-Antonczyk KM; Stokke BT; Sundan A; Arum CJ; Brede G
Exp Cell Res; 2019 Oct; 383(1):111490. PubMed ID: 31283912
[TBL] [Abstract][Full Text] [Related]
4. MET/HGF pathway in multiple myeloma: from diagnosis to targeted therapy?
Gambella M; Palumbo A; Rocci A
Expert Rev Mol Diagn; 2015; 15(7):881-93. PubMed ID: 25967746
[TBL] [Abstract][Full Text] [Related]
5. Immunohistochemical analysis of hepatocyte growth factor and c-Met in plasma cell disease.
Wader KF; Fagerli UM; Børset M; Lydersen S; Hov H; Sundan A; Bofin A; Waage A
Histopathology; 2012 Feb; 60(3):443-51. PubMed ID: 22276607
[TBL] [Abstract][Full Text] [Related]
6. Engineered mutants of HGF/SF with reduced binding to heparan sulphate proteoglycans, decreased clearance and enhanced activity in vivo.
Hartmann G; Prospero T; Brinkmann V; Ozcelik C; Winter G; Hepple J; Batley S; Bladt F; Sachs M; Birchmeier C; Birchmeier W; Gherardi E
Curr Biol; 1998 Jan; 8(3):125-34. PubMed ID: 9443912
[TBL] [Abstract][Full Text] [Related]
7. The role of hepatocyte growth factor and its receptor c-Met in multiple myeloma and other blood malignancies.
Børset M; Seidel C; Hjorth-Hansen H; Waage A; Sundan A
Leuk Lymphoma; 1999 Jan; 32(3-4):249-56. PubMed ID: 10037022
[TBL] [Abstract][Full Text] [Related]
8. Expression of c-Met and heparan-sulfate proteoglycan forms of CD44 in colorectal cancer.
Wielenga VJ; van der Voort R; Taher TE; Smit L; Beuling EA; van Krimpen C; Spaargaren M; Pals ST
Am J Pathol; 2000 Nov; 157(5):1563-73. PubMed ID: 11073815
[TBL] [Abstract][Full Text] [Related]
9. Isolation and Characterization of a Chinese Hamster Ovary Heparan Sulfate Cell Mutant Defective in Both Met Receptor Binding and Hepatocyte Growth Factor NK1/Met Signaling.
Cao T; Pan J; Li X; He Y; Jiang Y; Chang Y; Zhang Q; Lan Y; Wang H; Jiao W; Tian Z; Zhang L
Cell Physiol Biochem; 2018; 48(4):1480-1491. PubMed ID: 30107380
[TBL] [Abstract][Full Text] [Related]
10. A selective c-met inhibitor blocks an autocrine hepatocyte growth factor growth loop in ANBL-6 cells and prevents migration and adhesion of myeloma cells.
Hov H; Holt RU; Rø TB; Fagerli UM; Hjorth-Hansen H; Baykov V; Christensen JG; Waage A; Sundan A; Børset M
Clin Cancer Res; 2004 Oct; 10(19):6686-94. PubMed ID: 15475459
[TBL] [Abstract][Full Text] [Related]
11. A HGF/cMET autocrine loop is operative in multiple myeloma bone marrow endothelial cells and may represent a novel therapeutic target.
Ferrucci A; Moschetta M; Frassanito MA; Berardi S; Catacchio I; Ria R; Racanelli V; Caivano A; Solimando AG; Vergara D; Maffia M; Latorre D; Rizzello A; Zito A; Ditonno P; Maiorano E; Ribatti D; Vacca A
Clin Cancer Res; 2014 Nov; 20(22):5796-807. PubMed ID: 25212607
[TBL] [Abstract][Full Text] [Related]
12. Heparanase plays a dual role in driving hepatocyte growth factor (HGF) signaling by enhancing HGF expression and activity.
Ramani VC; Yang Y; Ren Y; Nan L; Sanderson RD
J Biol Chem; 2011 Feb; 286(8):6490-9. PubMed ID: 21131364
[TBL] [Abstract][Full Text] [Related]
13. Hepatocyte growth factor-mediated renal epithelial branching morphogenesis is regulated by glypican-4 expression.
Karihaloo A; Kale S; Rosenblum ND; Cantley LG
Mol Cell Biol; 2004 Oct; 24(19):8745-52. PubMed ID: 15367691
[TBL] [Abstract][Full Text] [Related]
14. c-Met signaling promotes IL-6-induced myeloma cell proliferation.
Hov H; Tian E; Holien T; Holt RU; Våtsveen TK; Fagerli UM; Waage A; Børset M; Sundan A
Eur J Haematol; 2009 Apr; 82(4):277-87. PubMed ID: 19187270
[TBL] [Abstract][Full Text] [Related]
15. Hepatocyte growth factor and its receptor c-met in multiple myeloma.
Börset M; Hjorth-Hansen H; Seidel C; Sundan A; Waage A
Blood; 1996 Nov; 88(10):3998-4004. PubMed ID: 8916966
[TBL] [Abstract][Full Text] [Related]
16. Anti-c-MET Nanobody - a new potential drug in multiple myeloma treatment.
Slørdahl TS; Denayer T; Moen SH; Standal T; Børset M; Ververken C; Rø TB
Eur J Haematol; 2013 Nov; 91(5):399-410. PubMed ID: 23952536
[TBL] [Abstract][Full Text] [Related]
17. Decorin is down-regulated in multiple myeloma and MGUS bone marrow plasma and inhibits HGF-induced myeloma plasma cell viability and migration.
Kristensen IB; Pedersen L; Rø TB; Christensen JH; Lyng MB; Rasmussen LM; Ditzel HJ; Børset M; Abildgaard N
Eur J Haematol; 2013 Sep; 91(3):196-200. PubMed ID: 23607294
[TBL] [Abstract][Full Text] [Related]
18. The hepatocyte growth factor/Met pathway controls proliferation and apoptosis in multiple myeloma.
Derksen PW; de Gorter DJ; Meijer HP; Bende RJ; van Dijk M; Lokhorst HM; Bloem AC; Spaargaren M; Pals ST
Leukemia; 2003 Apr; 17(4):764-74. PubMed ID: 12682635
[TBL] [Abstract][Full Text] [Related]
19. Cross-talk between CD44 and c-Met in B cells.
Taher TE; van der Voort R; Smit L; Keehnen RM; Schilder-Tol EJ; Spaargaren M; Pals ST
Curr Top Microbiol Immunol; 1999; 246():31-7; discussion 38. PubMed ID: 10396036
[No Abstract] [Full Text] [Related]
20. High concentration but low activity of hepatocyte growth factor in periodontitis.
Lönn J; Johansson CS; Nakka S; Palm E; Bengtsson T; Nayeri F; Ravald N
J Periodontol; 2014 Jan; 85(1):113-22. PubMed ID: 23594192
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
